Research Paper Volume 13, Issue 6 pp 8155—8176

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma


Figure 3. Nomogram for predicting the probability of 1-, 3- and 5-year OS for LUAD patients. (AD) A nomogram that integrates FAM72A-D and other prognostic factors in LUAD from TCGA data.